Zelboraf And Yervoy Benefit From Secret Discounts To Pass NICE Barrier
This article was originally published in The Pink Sheet Daily
Executive Summary
NICE has recommended Roche’s Zelboraf and BMS’ Yervoy, as expected based partly on undeniable life extension capabilities, but also on secret price discounts offered by both manufacturers.